Table 1.
Baseline characteristics of study population.
Fig 1.
The distribution of LS and CAP values according to histologic fibrosis and steatosis grade.
The bar lines mean the range of each grade of steatosis and fibrosis. LS, liver stiffness; CAP, controlled attenuation parameter.
Table 2.
Diagnostic performance of CAP for assessing hepatic steatosis in patients with NAFLD.
Table 3.
Diagnostic performance of LS for assessing liver fibrosis in patients with NAFLD
Table 4.
Independent predictors of NASH and corresponding rounded risk score for CLA score.
Table 5.
CLA score and corresponding NASH prevalence.
Fig 2.
Internal validation of CLA scores for predicting NASH.
AUROC, area under receiver operating characteristic curve; CI, confidence interval.